Phase III Study Comparing the Combination of DOXIL/CAELYX and YONDELIS With DOXIL/CAELYX Alone in Subjects With Advanced Relapsed Ovarian Cancer .

.

An Open-Label Multicenter Randomized .

Yondelis in Metastatic Breast Cancer Patients With Triple Negative Profile (ER-, PR-, HER2-), HER2 Overexpressing Tumors and BRCA1 or BRCA2 Mutation

.
Phase II, Multicenter, Open-label.

Yondelis for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment .

.

A Multicenter, Open-label Single-arm .

Yondelis Phase III Trial Versus Doxorubicin-based Chemotherapy as First-Line Therapy in Patients With T.R.S. . A Randomized, Multicenter .

Una muestra de orina permite diagnosticar el cáncer de vejiga .